Fidelity Advisor Srs Vii: Fideli: (MF: FACDX)
NAV
$28.70
NAV Day Change
-0.22 (-0.76%)
May 20 06:05 PM ET
General Information As Of 04/30/13
| %Yield | 0.00 |
| %SEC Yield | NA |
| %YTD Return (as of 04/30/13) | 18.34 |
| Objective* | Equity - Sector Health |
| Peer* | HL MG |
Portfolio Statistics
| %Unrealized Gain YTD | 20.17 |
| Net Assets (Mil $) 04/30/2013 | 303.23 |
| %Turnover 04/30/2013 | 87.00 |
Fees
| %Max Sales Load | 5.75 |
| %Min Sales Load | .00 |
| %Max Deferred Load | NA |
Expenses
| %Max 12b-1 Fee | 0.25 |
| %Max Management Fee | 0.56 |
| Redemption Fee | 0.75 |
| Expense Ratio | 1.17 |
Allocation
| Large Growth | 42.93 |
| Large Value | 0.00 |
| Small Growth | 0.00 |
| Small Value | 0.00 |
| Foreign Stock | 0.00 |
| Emerging Market | 0.00 |
| Precious Metal | 0.00 |
| Intermediate Bond | 0.00 |
| Foreign Bond | 0.00 |
| High Yield Bond | 28.21 |
Portfolio Information
Composition
| As of 01/31/2013 | %of Net Assets |
| Stock | 99.12 |
| Cash | 3.56 |
| Bonds | 0.00 |
| Preferred | 0.00 |
| Convertibles | 0.43 |
| Foreign Stock | 8.14 |
| Foreign Bonds | 0.00 |
| Hedge | 0.00 |
| Other | -3.11 |
Sector / Country Weightings
| As of 04/30/2013 | % of Portfolio |
|---|---|
| Health | 56.42 |
| Services | 16.76 |
| Finance | 9.60 |
| Retail Trade | 5.36 |
| Other | 4.74 |
| Technology | 4.46 |
| Industrial Cyclical | 2.49 |
| Non-Durable | 0.17 |
Portfolio Holdings
| Top Equity Holdings (As of 10/31/2012) | % of Portfolio | Value (Mil$) |
|---|---|---|
| MERCK + CO. INC. | 9.11 | 46.20 |
| AMGEN INC | 7.95 | 40.31 |
| PFIZER INC | 6.73 | 34.11 |
| GILEAD SCIENCES INC | 4.94 | 25.05 |
| UNITEDHEALTH GROUP INC | 3.69 | 18.69 |
| CATAMARAN CORP | 3.00 | 15.20 |
| ELI LILLY + CO | 2.90 | 14.70 |
| JOHNSON + JOHNSON | 2.88 | 14.59 |
| WATSON PHARMACEUTICALS | 2.61 | 13.26 |
Contact Information
| Family | Fidelity |
| Addrerss | 82 Devonshire St Boston, MA 02109 |
| Phone | 800 544-6666 |
Zacks Premium Research
Zacks Mutual Fund Rank: 1 - Strong Buy 
| #1 |
Fund Description
The fund was incepted in September 1996 and is managed by the Fidelity Group. The fund's main objective is to seek capital appreciation. The fund normally invests in common stocks. The fund invests at least 80% of assets in securities of companies principally engaged in the design, manufacture, or sale of products or services used for or in connection with health care or medicine. The management may invest in securities of foreign and domestic issuers. Dividends and capital gains, if any, are distributed annually in December.
Stock Holding % of Net Assets
| As Of | 01/31/2013 |
| Total Issues | 105 |
| Avg. P/E | 27.94 |
| Avg. P/Book | 4.92 |
| Avg. EPS Growth | 13.79 |
| Avg. Market Value (Mil $) | 40,749 |
Risk
| 3 Year | 5 Year | 10 Year | |
|---|---|---|---|
| Beta | 0.85 | 0.81 | 0.80 |
| Alpha | 7.17 | 8.16 | 2.99 |
| R Squared | 0.80 | 0.79 | 0.70 |
| Std. Dev. | 14.28 | 17.25 | 14.22 |
| Sharpe | 1.38 | 0.82 | 2.00 |
Shareholder Information
| Manager | Edward Yoon |
| Since | 10/08 |
| Manager Rating | 6.70 |
| Inception Date | 09/03/1996 |
| Shareholders | 15395 |
| Dividends Paid | A |
| Minimum Initial Investment | $2,500 |
| Minimum Subsequent Investment | $0 |
| IRA Minimum | $500 |
| IRA Available | Y | Check Writing | N | Phone Invest | Y |
| Phone Exchange | Y | Phone Redeem | Y | Auto Invest | Y |
| Wire Redeem | Y | Wire Fee | Y | Wire Transfer | Y |
Zacks Commentary for FACDX
Zacks Blog: Top 5 Zacks #1 Ranked Fidelity Mutual Funds
Jan 02, 2013
Zacks Blog: Top 5 Zacks #1 Ranked Fidelity Mutual Funds
Oct 09, 2012
